Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Donepezil in pediatric cancer survivors with attention impairment
NCT00688376Phase 3Completed
- Sponsor
- Eisai Co., Ltd.
- Start
- Jul 2008
- Primary completion
- May 2009
- Modality
- Small Molecules
- Countries
- 10
01
Overview
A Phase 3 trial of donepezil in attention deficit hyperactivity disorder (ADHD), cognitive dysfunction, sponsored by Eisai Co., Ltd.. Started Jul 2008; status: completed.
02
Drugs
donepezil
03
Conditions
attention deficit hyperactivity disorder (ADHD)cognitive dysfunction
Beyond the preview
Go deeper on NCT00688376.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00688376.